CCG-100602

• Description :

  CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 µM) .

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  478.82

• Molecular Formula :

  C21H17ClF6N2O2

• Notes :

  Research use only, not for human use.

• Receptor :

  Rho

• CAS Number :

  1207113-88-9